Drug Monitoring, Eszopiclone, Quantitative, Urine

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Eszopiclone Comments

ESZOPICLONE METABOLITE

Zopiclone Quantitation,

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Drug Monitoring, Eszopiclone, Quantitative, Urine test contains 1 test with 3 biomarkers.

Drug Monitoring, Eszopiclone, Quantitative, Urine

Clinical Significance
Drug Monitoring, Eszopiclone, Quantitative, Urine - Zopiclone is used to treat patients with insomnia. This test is used to detect the presence of the drug as a therapeutic drug monitoring and to aide clinicians with the drug's dosage effectiveness.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Eszopiclone and Eszopiclone Metabolite

Reference Range(s)
Eszopiclone    <5 ng/mL
Eszopiclone Metabolite    <5 ng/mL

Alternative Name(s)
Lunesta®,Prescription Drug Monitoring,Pain Management

Customer Reviews